rimuovere Forza motrice Viscoso migraine interictal burden scale In particolare Cereale eccitazione
Safety and efficacy of galcanezumab in patients for whom previous migraine preventive medication from two to four categories had failed (CONQUER): a multicentre, randomised, double-blind, placebo-controlled, phase 3b trial - The Lancet
Measuring interictal burden among people affected by migraine: a descriptive survey study | The Journal of Headache and Pain | Full Text
Global epidemiology of migraine and its implications for public health and health policy | Nature Reviews Neurology
MIBS - "Migraine Interictal Burden Scale" by AcronymsAndSlang.com
Scientific Poster Template 4x5, Updated 2019
Changes in migraine interictal burden following treatment with galcanezumab: Results from a phase III randomized, placebo‐controlled study - Lipton - 2023 - Headache: The Journal of Head and Face Pain - Wiley Online Library
A Big-Picture Look at the Burden of Migraine
Assessing and managing all aspects of migraine: migraine attacks, migraine-related functional impairment, common comorbidities, and quality of life. - Abstract - Europe PMC
Burden of Migraine in Japan: Results of the ObserVational Survey of the Epidemiology, tReatment, and Care Of MigrainE (OVERCOME [Japan]) Study | Neurology and Therapy
Burden of Migraine in Japan: Results of the ObserVational Survey of the Epidemiology, tReatment, and Care Of MigrainE (OVERCOME [Japan]) Study | Neurology and Therapy
IJMS | Free Full-Text | Excitation-Inhibition Imbalance in Migraine: From Neurotransmitters to Brain Oscillations
Assessing and managing all aspects of migraine: migraine attacks, migraine-related functional impairment, common comorbidities, and quality of life - Document - Gale Academic OneFile
Assessing Functional Impairment During and Between Migraine Attacks
Assessing and managing all aspects of migraine: migraine attacks, migraine-related functional impairment, common comorbidities, and quality of life. - Abstract - Europe PMC
CONQUER Clinical Study Efficacy Data for Emgality® (galcanezumab-gnlm)
Migraine-attributed burden, impact and disability, and migraine-impacted quality of life: Expert consensus on definitions from a Delphi process - Timothy J Steiner, Gisela M Terwindt, Zaza Katsarava, Patricia Pozo-Rosich, Andreas R Gantenbein,
Scientific Poster Template 4x5, Updated 2019
Proportions of participants with headache reporting interictal burden,... | Download Table
Real-life experiences with galcanezumab and predictors for treatment response in Turkey | springermedizin.de
Burden and Unmet Needs in Migraine Patients: Results from the OVERCOME (Spain) Study | Pain and Therapy
The use of clinical scales and PROMs in headache disorders and migraine, summarizing their dissemination and operationalization - ScienceDirect
Burden of migraine: A ripple effect from individuals to society
Medication Overuse and Headache Burden | Neurology Clinical Practice
How to address the full impact of migraine | Progress In Mind
CONQUER Clinical Study Efficacy Data for Emgality® (galcanezumab-gnlm)